BRIEF published on 09/04/2025 at 17:50, 10 months 3 days ago Accor's Share Capital and Voting Rights as of August 2025 Voting Rights French Commercial Code Accor Financial Disclosure Shares Outstanding
REGULATED PRESS RELEASE published on 09/04/2025 at 17:45, 10 months 3 days ago Disclosure of shares outstanding and voting rights - 04.09.2025 Accor discloses share capital and voting rights pursuant to the French Commercial Code. Total potential and exercisable voting rights outlined Share Capital Voting Rights French Commercial Code Accor Disclosure
BRIEF published on 08/27/2025 at 19:30, 10 months 11 days ago Accor Successfully Issues €500 Million Senior Bond Accor Market Conditions Investor Confidence Bond Issuance Debt Refinancing
REGULATED PRESS RELEASE published on 08/27/2025 at 19:25, 10 months 11 days ago Accor announces the success of its new senior bond issuance Accor successfully completes €500 million 7-year bond issuance with 3.625% annual coupon, oversubscribed 3 times. Proceeds to refinance outstanding debt. Rated BBB- Accor Bond Issuance Oversubscribed BBB- 3.625%
BRIEF published on 08/05/2025 at 17:50, 11 months 2 days ago Accor Releases Share and Voting Rights Information Voting Rights French Commercial Code Accor Shareholder Transparency Shares Outstanding
REGULATED PRESS RELEASE published on 08/05/2025 at 17:45, 11 months 2 days ago Disclosure of shares outstanding and voting rights - 05.08.2025 Accor discloses share capital and voting rights as of July 31, 2025, pursuant to French Commercial Code. Total potential voting rights: 285,367,933 Share Capital Voting Rights French Commercial Code Accor Disclosure
BRIEF published on 08/04/2025 at 08:35, 11 months 4 days ago Accor Launches €240 Million Tranche of Share Buyback Program Accor Share Buyback Investment 2025 €240 Million
REGULATED PRESS RELEASE published on 08/04/2025 at 08:30, 11 months 4 days ago Launch of a €240 million tranche of its share buyback program Accor announces the launch of a €240 million tranche for its share buyback program, part of a total program of €440 million set for 2025 Accor Investor Relations Share Buyback Program Financial Communications €240 Million Tranche
BRIEF published on 07/31/2025 at 07:35, 11 months 8 days ago Accor Releases 2025 Interim Financial Report Euronext Paris Financial Performance Accor AMF Filing 2025 Interim Report
BRIEF published on 07/31/2025 at 07:35, 11 months 8 days ago Accor's Steady Growth Amidst Macroeconomic Challenges in H1 2025 Share Buyback Hotel Expansion RevPAR Growth 2025 Financial Performance Accor Revenue
Published on 07/08/2026 at 08:00, 2 hours 2 minutes ago Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 07/08/2026 at 03:25, 6 hours 37 minutes ago Linear Provides Update on Proposed Acquisition of Critical Prospecting Corp
Published on 07/08/2026 at 01:10, 8 hours 52 minutes ago Galantas Announces Resignation of Chair of the Board
Published on 07/07/2026 at 23:15, 10 hours 47 minutes ago Guanajuato Silver Announces Officer Resignation
Published on 07/07/2026 at 22:15, 11 hours 47 minutes ago Grande Portage Closes C$6 Million Equity Financing
Published on 07/08/2026 at 09:05, 56 minutes ago Voiskey Officially Launches: The First AI Voice Typing App Focused on Expression Intelligence
Published on 07/08/2026 at 09:00, 1 hour 1 minute ago Original-Research: Emerald Horizon AG (von NuWays AG): BUY
Published on 07/08/2026 at 09:00, 1 hour 1 minute ago Original-Research: The NAGA Group AG (von NuWays AG): BUY
Published on 07/07/2026 at 18:10, 15 hours 51 minutes ago LNA Santé and Euryale join forces to expand hospitalisation at home services across healthcare regions
Published on 07/07/2026 at 18:05, 15 hours 57 minutes ago Covivio - Half-yearly report on the liquidity contract on 30 June 2026
Published on 07/07/2026 at 18:01, 16 hours 1 minute ago Covivio - Information on total number of voting rights and share capital
Published on 07/07/2026 at 18:00, 16 hours 2 minutes ago Share Buyback Offer (OPRA) favored to implement shareholder return following the sale of Novacel
